CDKN2A and metabolic syndrome: Similarly, obesity and dyslipidemia can increase senescence markers, such as senescence-associated β-galactosidase activity and p16, p19, p21, and p53 gene expression in many cell types, including cells of adipose tissue, aorta, pancreas, liver, and endothelium (27–32).